drugset / Trial / NCT01466673

An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment

NCT01466673

Phase 4 Completed 201 enrolled Janssen-Cilag Ltd.,Thailand
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Ethinyl estradiol and Norgestimate (EE/NGM) compared to Ethinyl estradiol and Desogestrel (EE/DSG), for treatment of female participants with mild to moderate acne vulgaris (pimples).

Timeline

Start
2008-12
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desogestrel Small molecule 0.125 mg Oral
Subject Norgestimate Small molecule 0.25 mg Oral
Comparator ethinyl estradiol Small molecule 0.03 mg Oral
Comparator ethinyl estradiol Small molecule 0.035 mg Oral
Comparator ethinyl estradiol Small molecule 0.04 mg Oral

Indications